The treatment of orthostatic hypotension with dihydroxyphenylserine

R. Freeman*, L. Landsberg

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Neurogenic orthostatic hypotension is an incapacitating symptom of central and peripheral autonomic nervous system degeneration. It occurs in such clinical conditions as multiple system atrophy, pure autonomic failure, and small-fiber peripheral neuropathies. Although many treatments are available, their effects are inconsistent, unsustained, and complicated by side effects. 3,4-Dihydroxyphenylserine is a synthetic, unnatural amino acid that is an immediate norepinephrine precursor. There is theoretical and clinical evidence supporting the use of this agent in the treatment of neurogenic orthostatic hypotension in patients with peripheral and central autonomic nervous system dysfunction. We review the biochemistry, pharmacokinetics, and possible mechanisms of action and clinical utility of this agent in the treatment of neurogenic orthostatic hypotension.

Original languageEnglish (US)
Pages (from-to)296-304
Number of pages9
JournalClinical neuropharmacology
Issue number4
StatePublished - 1991


  • 3,4-Dihydroxyphenylserine
  • Autonomic nervous system degeneration
  • Neurogenic orthostatic hypotension
  • Norepinephrine

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)


Dive into the research topics of 'The treatment of orthostatic hypotension with dihydroxyphenylserine'. Together they form a unique fingerprint.

Cite this